|
|
|
Insider
Information: |
Loy Bertrand |
Relationship: |
Director |
City: |
Acton |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
323,083 |
|
Indirect Shares
|
499,633 |
|
|
Direct
Value |
$35,388,590 |
|
|
Indirect Value
|
$1,446,438 |
|
|
Total
Shares |
822,716 |
|
|
Total
Value |
$36,835,027 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
0
|
Stock
price went up :
|
7
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
Percentage
Gain/Loss : |
71.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Director |
2024-05-21 |
56,575 |
2024-05-21 |
499,633 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BTUI |
BTU International Inc |
Director |
|
2015-01-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,701) |
0 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2021-08-11 |
4 |
AS |
$116.04 |
$2,766,024 |
I/I |
(23,710) |
0 |
0 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-09-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(108,715) |
0 |
0 |
- |
|
BTUI |
BTU International Inc |
Director |
|
2016-01-26 |
4 |
OE |
$2.18 |
$7,499 |
D/D |
3,440 |
3,440 |
0 |
- |
|
BTUI |
BTU International Inc |
Director |
|
2015-01-26 |
4 |
OE |
$2.30 |
$14,550 |
D/D |
6,261 |
9,701 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
14,400 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2021-08-10 |
4 |
AS |
$119.87 |
$7,802,148 |
I/I |
(65,000) |
23,710 |
0 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,800 |
26,200 |
0 |
- |
|
ENTG |
Entegris Inc |
Executive V.P. & CAO |
|
2005-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
49,299 |
49,299 |
|
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
52,900 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2024-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,575 |
56,575 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,600 |
70,500 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
31,516 |
79,009 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2021-08-09 |
4 |
AS |
$121.03 |
$7,897,079 |
I/I |
(65,000) |
88,710 |
0 |
% |
|
ENTG |
Entegris Inc |
President & CEO |
|
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
91,000 |
91,000 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
31,300 |
101,800 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
117,750 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
135,850 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-11 |
4 |
B |
$3.01 |
$46,926 |
D/D |
15,590 |
138,674 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
149,850 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-12 |
4 |
B |
$3.07 |
$34,682 |
D/D |
11,297 |
149,971 |
2.39 |
- |
|
ENTG |
Entegris Inc |
Exec VP & COO |
|
2012-01-18 |
4 |
AS |
$9.20 |
$755,522 |
D/D |
(82,122) |
151,980 |
0 |
- |
|
ENTG |
Entegris Inc |
President & CEO |
|
2021-08-04 |
4 |
AS |
$125.41 |
$4,914,665 |
I/I |
(39,178) |
153,710 |
0 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-13 |
4 |
B |
$3.11 |
$22,927 |
D/D |
7,372 |
157,343 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-11-08 |
4 |
B |
$2.64 |
$17,466 |
D/D |
6,616 |
163,959 |
2.39 |
- |
|
177 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|